Highlights:
- Physicians posit that equipoise likely remains between general anaesthesia and conscious sedation in endovascular therapy following the presentation of SEGA trial results at the Society of Vascular and Interventional Neurology (SVIN) annual meeting (16–18 November 2023, Miami, USA)
- Discussions at this year’s European Society of Minimally Invasive Neurological Therapy (ESMINT) congress (4–6 September, Marseille, France) indicate that “the tables have turned” when it comes to neurovascular device regulation, with many Europeans becoming envious of their US counterparts
- PROFILE: Phil White (Newcastle, UK) outlines his journey to being appointed as the UK’s second ever professor of interventional neuroradiology, also discussing upcoming chronic subdural haematoma trials, tenecteplase, and several other hot topics in the neurointerventional space
- CAROTID: The US Centers for Medicare & Medicade Services (CMS) announces its final decision over the expanded coverage of carotid artery stenting procedures
- NEUROMODULATION: Intrathecal drug delivery systems are deemed effective in the management of cancer-related pain, as per two recent systematic reviews and meta-analyses
